In partnership with
The EverLife Capital Brief · November 4, 2026
We don't age from one thing. We age from many small things breaking. Each issue covers one part of the body: what's proven to help now, what the experts are doing, and the newest science. Today: your blood vessels.
Which one cut strokes in a 21,000-person trial?
Today in 3 minutes:
Paid links: EverLife Capital earns a referral fee if you subscribe (one click), and is paid per click on sponsor messages. I only include things I believe can help you.
For simple daily health habits: ArcaMax Health & Fitness is a free newsletter with exercise tips, nutrition information and healthy living advice. Try ArcaMax Health & Fitness free →
A paid message from today's sponsor: chef-made meals delivered, for the nights you'd rather not cook.
Let world-class chefs answer your cravings.
Tired of the same meal prep on repeat? CookUnity can help. Because they connect you with 500+ meals handcrafted by over 130 world-class chefs, including Michelin-starred chefs and Food Network stars.
Explore 60+ different cuisines and diets, and choose dishes that fit your cravings and preferences. Your meals arrive fresh and ready to heat in minutes, so no prep or cleanup.
Whether you're in the mood for a comforting classic or a new flavor, there's always something new to discover because the menu rotates weekly, and their chefs are always creating new recipes.
Explore the menu available in your area and build a weekly plan you can skip, pause, or adjust anytime.
Do This Now: The Kitchen Swap That Cut Strokes
Shown in: people, about 21,000 adults in rural China (average age 65) who had a past stroke or were 60+ with high blood pressure, followed for almost 5 years.
In the SSaSS trial, people who swapped regular salt for a potassium-based salt substitute had 14% fewer strokes and 12% fewer deaths than those who kept using regular salt, with no rise in dangerous potassium levels. Fish oil and vitamin D, by contrast, did not lower strokes in the large VITAL trial of healthy adults. So if you guessed the salt swap above, you were right.
How: look for a salt substitute that lists potassium chloride on the label and use it the way you use salt.
Who should check first: anyone with kidney disease, or who takes drugs that raise potassium (some blood pressure and heart medicines, potassium-sparing water pills). Ask your doctor before switching.
Source: Neal et al., New England Journal of Medicine, 2021 (SSaSS); Manson et al., NEJM, 2019 (VITAL)
Do This Now: The Home Blood Pressure Check, Done Right
Shown in: people (the SPRINT MIND trial, JAMA, 2019).
In SPRINT, people treated to a lower blood pressure target had 19% less mild cognitive impairment, often the first step toward dementia. But small mistakes, like talking or a cuff over a sleeve, can push a reading several points too high.
For a true reading: use a cuff listed at validatebp.org; no coffee, exercise or smoking for 30 minutes before; sit with your back supported and feet flat for 5 minutes without talking; cuff on a bare upper arm resting at heart level; take 2 readings a minute apart, morning and evening, for a week, and bring the log to your doctor.
Source: Williamson et al., JAMA, 2019 (SPRINT MIND); American Heart Association
EverLife Capital Members
Look Beyond The Breakthrough Headlines
Members get plain-English analysis of each company we cover: who the results were shown in, and the warning signs to check before putting money in. You can also ask us to analyze the companies you care about. Free for 14 days.
Biotechnology investments can lose substantial value, including your entire investment. Clinical success or regulatory approval does not guarantee commercial success or investment returns.
What The Experts Changed: The New Blood Pressure Rules
Heart doctors' latest US guideline (American Heart Association and American College of Cardiology, 2025) changed how high blood pressure is handled:
→ Target: under 130/80 for nearly everyone, with under 120 systolic encouraged. Keeping systolic under 130 is now also recommended to help protect against memory loss and dementia.
→ Start with two drugs: at 140/90 or higher, start lifestyle changes plus two medicines at once, usually combined in one pill.
→ Salt substitutes: now recommended, with the kidney and medication cautions above.
→ Skip the smartwatch: cuffless devices are not yet accurate enough to rely on.
→ One test to ask for: if you have high blood pressure, a urine albumin test, which can catch kidney damage earlier than standard blood work.
Source: 2025 AHA/ACC High Blood Pressure Guideline, via the American Medical Association, Sept 2025
New Science: A Pill Facing An FDA Decision Dec 22
Shown in: people, 59 adults with chronic kidney disease (average age about 65). Stage: FDA decision due Dec 22, 2026, for high blood pressure.
Only about 1 in 4 US adults with high blood pressure has it under control. One driver is aldosterone, a hormone that makes the body hold on to salt. Lorundrostat stops the body from making it. Taken once a day for 4 weeks alongside a standard kidney drug, it lowered systolic blood pressure 7.5 points more than placebo and cut protein leaking into the urine (a sign of kidney damage) by about 26%.
The catch: it was short and small, and it would not be first. AstraZeneca's baxdrostat (Baxfendy), a drug of the same type, was approved in May 2026.
Company: Mineralys Therapeutics (MLYS), public. $15.99 per share at the Nov 3 close, market value about $1.41 billion, cash and investments about $661 million (June 30, 2026), which the company says lasts into 2028.
Why it matters: a second option in a new drug class could help people whose current pills are not enough.
Source: Kidney International, Oct 28, 2026 (Explore-CKD), via Mineralys; Mineralys Q2 2026 report; CDC; FDA approval of baxdrostat, May 2026
For investors who want income while they wait: MaxDividends is a free newsletter on high-yield and dividend growth stocks for people who want passive income to live on, read by more than 25,000 people. Try MaxDividends free →
Saved For Last: One Gene Cut Frailty 44% In Old Mice
Shown in: mice (9 to 10 females per group), plus human skin cells in a dish. Stage: lab only, no company attached.
George Church's lab at Harvard switched on a single gene, SRSF1, in old mice. SRSF1 helps cells decide which version of a protein to make, a process that drifts with age. The mice became 44% less frail, healed wounds faster and lived 14% longer at the median. In human skin cells, gene activity shifted toward a younger pattern.
The catch: small groups, the effect was mostly in the liver, and keeping the gene switched on all the time did not help healing, so timing seems to matter.
Source: Nature Aging, 2026, vol. 6(10), via Lifespan.io, Oct 28, 2026
For your retirement years: ArcaMax Senior Living is a free newsletter with news on health, travel and retirement. Try ArcaMax Senior Living free →
Hit reply and tell me: which part of your body should I cover next, or one health worry you want me to dig into? I read every reply.
Want to advertise in EverLife Capital? Reach readers focused on aging well and longevity science. Email [email protected]. We do not accept payment, directly or through agencies, from companies we cover.
EverLife Capital publishes general educational research, not personalized investment or medical advice, and nothing here is a recommendation to buy or sell any security. EverLife Capital earns referral fees when readers subscribe to ArcaMax Health & Fitness, MaxDividends or ArcaMax Senior Living through this issue, and is paid per click on sponsor messages; no company covered in this issue paid for coverage, directly or indirectly. Early clinical findings and animal results may not lead to lasting benefits for patients, and clinical progress does not guarantee investment returns. Treatment and supplement decisions belong with a qualified clinician. Prices are dated where shown and may have changed. EverLife Capital is published by Consult US, LLC. Neither Eric Pemper nor Consult US, LLC holds positions in companies mentioned. Some research and summaries are prepared with AI assistance and reviewed before publication.
